| Title |
Author |
Type |
Date |
Words |
| Opthea receives funding for OPT-302 trials, pre-commercialization activities. |
|
|
Aug 15, 2022 |
177 |
| Cognition Therapeutics reports Q2 EPS (25c), consensus (32c). |
|
Financial report |
Aug 9, 2022 |
180 |
| OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration. |
|
|
Aug 8, 2022 |
256 |
| OliX Pharmaceuticals granted FDA approval to develop RNAi therapeutic for AMD. |
|
|
Aug 3, 2022 |
155 |
| OliX Pharmaceuticals granted FDA approval to develop RNAi therapeutic for AMD. |
|
|
Aug 3, 2022 |
156 |
| EyePoint Pharmaceuticals doses first patient in phase two 'Durasert and Vorolanib in Ophthalmology 2' EYP-1901 clinical trial. |
|
|
Aug 2, 2022 |
294 |
| EyePoint Pharmaceuticals doses first patient in phase two 'Durasert and Vorolanib in Ophthalmology 2' EYP-1901 clinical trial. |
|
|
Aug 2, 2022 |
295 |
| Control Some of Your AMD Risk. |
Etingin, Orli R. |
|
Jul 31, 2022 |
361 |
| Reduce Your Risk of Age-Related Macular Degeneration: Eye exams are essential; the earlier AMD is diagnosed and treated, the less likely it is to cause blindness. |
|
|
Jul 31, 2022 |
750 |
| Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration. |
Toulouie, Sara; Chang, Sean; Pan, Julia; Snyder, Kiersten; Yiu, Glenn |
Clinical report |
Jul 31, 2022 |
6300 |
| Akari Therapeutics announces results from preclinical studys of PAS-nomacopan. |
|
Financial report |
Jul 28, 2022 |
716 |
| LumiThera Acquires Assets of Diagnostic Tool Developer MacuLogix. |
|
|
Jul 27, 2022 |
222 |
| LumiThera Acquires Assets of Diagnostic Tool Developer MacuLogix. |
|
|
Jul 27, 2022 |
245 |
| Clearside Biomedical completes dosing in OASIS Phase 1/2a trial of CLS-AX. |
|
|
Jul 26, 2022 |
247 |
| Apellis announces FDA acceptance, priority review of NDA for pegcetacoplan. |
|
|
Jul 19, 2022 |
177 |
| EyePoint Pharmaceuticals reveals 12-month data from Phase 1 'Durasert and Vorolanib in Ophthalmology' (DAVIO) clinical trial assessing EYP-1901. |
|
|
Jul 18, 2022 |
384 |
| EyePoint Pharmaceuticals reveals 12-month data from Phase 1 'Durasert and Vorolanib in Ophthalmology' (DAVIO) clinical trial assessing EYP-1901. |
|
|
Jul 18, 2022 |
383 |
| Breakthrough treatment for Dry AMD Now available locally in Brigg, North Lincolnshire; ADVERTISING FEATURE New TREATMENT to help sufferers see better. |
|
|
Jul 15, 2022 |
307 |
| Adverum Biotechnologies presents new data from OPTIC study during ASRS. |
|
|
Jul 15, 2022 |
397 |
| EyePoint reports 'positive' 12-month data from Phase 1 trial of EYP-1901. |
|
|
Jul 15, 2022 |
312 |
| Genentech announces new two-year data from TENAYA, LUCERNE studies. |
|
|
Jul 14, 2022 |
392 |
| REGENXBIO completes enrolment in Cohort 5 of Phase II AAVIATE trial of RGX-314. |
|
|
Jul 11, 2022 |
212 |
| REGENXBIO completes enrolment in Cohort 5 of Phase II AAVIATE trial of RGX-314. |
|
|
Jul 11, 2022 |
211 |
| New group for blind in Callander. |
|
|
Jul 8, 2022 |
235 |
| Sight loss group in Callander. |
|
|
Jul 6, 2022 |
235 |
| DelSiTech and Iveric Bio sign licence agreement for development and commercialisation of sustained release Zimura. |
|
|
Jul 6, 2022 |
260 |
| DelSiTech and Iveric Bio sign licence agreement for development and commercialisation of sustained release Zimura. |
|
|
Jul 6, 2022 |
261 |
| DelSiTech and Iveric Bio sign licence agreement for development and commercialisation of sustained release Zimura. |
|
|
Jul 6, 2022 |
259 |
| Adverum Biotechnologies completes IND amendment with FDA for LUNA trial. |
|
|
Jul 6, 2022 |
252 |
| Iveric bio, DelSiTech in pact to develop sustained release Zimura. |
|
|
Jul 5, 2022 |
272 |
| Iveric Bio, DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura. |
|
|
Jul 5, 2022 |
564 |
| Primary Vitreoretinal Lymphoma: A Retrospective Study of 20 Eyes. |
Luo, Jing-Yi; Yu, Shi-Tong; Xu, Xiao-Yu; Lin, Xian-Xuan; Luo, Rong-Jiang; Long, Chong-De |
Report |
Jul 1, 2022 |
5140 |
| Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Injection on Intraocular Pressure and Systemic Blood Pressure. |
Beenish Saleem, Muhammad Azeem Khizer and Asfandyar Khan |
|
Jun 30, 2022 |
2539 |
| Drusen is not necessarily a sign of macular degeneration. |
|
|
Jun 20, 2022 |
541 |
| Short Communication - Neuroprotective Effect of Excitatory Amino Acid Receptor Antagonist on Retina of Rat. |
Fan, Chuanfeng; Feng, Wenguo; Yang, Jingchang; Chen, Qingchao; Wang, Yu |
Report |
Jun 11, 2022 |
2085 |
| Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare. |
Anderson, Kelly E.; Polsky, Daniel; Dy, Sydney; Sen, Aditi P. |
Report |
Jun 1, 2022 |
8158 |
| The Role of Omega-3 and Antioxidant Nutrients in Age-Related Macular Degeneration: A Review Article. |
Kocyigit, Emine; Tek, Nilufer Acar |
|
Jun 1, 2022 |
5147 |
| Outlook Therapeutics: FDA requests more information on ONS-5010 BLA. |
|
|
May 31, 2022 |
275 |
| Stealth Biotherapeutics reports Phase 2 results of elamipretide in GA. |
|
Financial report |
May 23, 2022 |
205 |
| Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases. |
Yang, Ming; Wang, Yanling |
|
May 20, 2022 |
8974 |
| UK Grants Licence for Teva's Ophthalmology Biosimilar Ongavia. |
|
|
May 17, 2022 |
324 |
| Unity Biotechnology reports Q1 EPS (28c), consensus (26c). |
|
Financial report |
May 10, 2022 |
173 |
| The Relationship between Statin and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. |
Memarzadeh, Ezatollah; Heidari-Soureshjani, Saeid |
Report |
May 9, 2022 |
5737 |
| Association between Cataract Surgery and Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. |
Yang, Lihong; Li, Hongxun; Zhao, Xinheng; Pan, Ye |
|
May 5, 2022 |
5675 |
| Unity Biotechnology presents on UBX1325 at ARVO 2022. |
|
|
May 5, 2022 |
322 |
| Cognition presents preclinical findings on sigma-2 receptor modulators. |
|
|
May 3, 2022 |
225 |
| Apellis announces longer-term data from DERBY, OAKS studies. |
|
|
May 2, 2022 |
324 |
| Three eye conditions affecting your sight and how the Nuffield Health Guildford Hospital can help; Nuffield Health Guildford Hospital's dedicated enquiry team are on hand to discuss the process with you. |
By, Russ Taylerson |
|
May 2, 2022 |
950 |
| 2022 Issue 3 at a Glance. |
Ozdemir, Hakan |
|
May 1, 2022 |
913 |
| Dry Eye and Meibomian Gland Dysfunction in Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Injections. |
Kiyat, Pelin; Palamar, Melis; Nalcaci, Serhad; Akkin, Cezmi |
|
May 1, 2022 |
3647 |
| Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association. |
Karabas, V. Levent; Tokuc, Ecem Onder; Sermet, Figen |
|
May 1, 2022 |
3831 |
| Mean Changes in Intraocular Pressure after Intravitreal Injection of Bevacizumab in Exudative Age Related Deneration and Proliferative Diabetic Retinopathy. |
Rebecca, Shafi Muhammad Jatoi, Fahad Feroz Shaikh and Muhammad Shahid |
|
Apr 30, 2022 |
2276 |
| PharmAbcine reveals positive results from PMC-403 GLP toxicology study. |
|
|
Apr 27, 2022 |
170 |
| PharmAbcine reveals positive results from PMC-403 GLP toxicology study. |
|
|
Apr 27, 2022 |
169 |
| Vision for the future: Nonprofit Hadley in Winnetka helps people with failing eyesight navigate life. |
Kim Becker kbecker@dailyherald.com |
|
Apr 27, 2022 |
651 |
| Samsara Vision to Initiate a US PMA Supplemental Study of the SING IMT, a New-Generation Technology for Age-Related Macular Degeneration. |
|
|
Apr 22, 2022 |
614 |
| Unity Biotechnology doses first patient in ENVISION study of UBX1325. |
|
|
Apr 19, 2022 |
180 |
| Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis. |
Yin, Xiaobei; He, Ting; Yang, Shanshan; Cui, Hui; Jiang, Wenlan |
|
Apr 15, 2022 |
6126 |
| Real-World Cataract Surgery Complications and Secondary Interventions Incidence Rates: An Analysis of US Medicare Claims Database. |
Terveen, Daniel; Berdahl, John; Dhariwal, Mukesh; Meng, Qian |
|
Apr 6, 2022 |
4348 |
| Adverum proceeds with IND amendment for wet AMD trial after FDA Type C feedback. |
|
|
Apr 6, 2022 |
245 |
| A Novel Smartphone-Based Color Test for Detection of Color Vision Defects in Age Related Macular Degeneration. |
Karampatakis, Vassilios; Almaliotis, Diamantis; Karamitopoulos, Leonidas; Kalliris, George; Almpanid |
|
Mar 31, 2022 |
7449 |
| Outlook Therapeutics submits BLA to US FDA for ONS-5010. |
|
|
Mar 31, 2022 |
259 |
| Graybug Vision announces update on pipeline programs. |
|
|
Mar 30, 2022 |
568 |
| Roche announces Vabysmo approved for nAMD and DME in Japan. |
|
|
Mar 28, 2022 |
166 |
| Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting. |
Rübsam, Anne; Rau, Saskia; Pilger, Daniel; Zeitz, Oliver; Joussen, Antonia M. |
Clinical report |
Mar 25, 2022 |
6395 |
| Apellis announces long-term data from Phase 3 DERBY, OAKS studies. |
|
|
Mar 16, 2022 |
260 |
| LumiThera completes debt financing agreement to support commercial activities. |
|
|
Mar 10, 2022 |
163 |
| LumiThera completes debt financing agreement to support commercial activities. |
|
|
Mar 10, 2022 |
164 |
| Nova MSC Collaborates with AMO and RHAZES to Bring its AI Deep Learning Technology, SELENA+ to Mainstream Adoption. |
|
|
Feb 21, 2022 |
894 |
| Retinal Blood Vessels and Optic Disc Segmentation Using U-Net. |
David, S. Alex; Mahesh, C.; Kumar, V. Dhilip; Polat, Kemal; Alhudhaif, Adi; Nour, Majid |
|
Feb 14, 2022 |
7211 |
| EyePoint Pharmaceuticals reveals updated interim data from 'Durasert and Vorolanib in Ophthalmology' phase one clinical trial of EYP-1901. |
|
|
Feb 14, 2022 |
323 |
| EyePoint Pharmaceuticals reveals updated interim data from 'Durasert and Vorolanib in Ophthalmology' phase one clinical trial of EYP-1901. |
|
|
Feb 14, 2022 |
324 |
| Know the ABCs of age-related macular degeneration. |
Submitted by American Society of Retina Specialists |
|
Feb 5, 2022 |
578 |
| TESTS FOR EVERYDAY VISUAL FUNCTION IN AMD PATIENTS. |
Powell, Selina |
|
Feb 1, 2022 |
220 |
| DIABETIC RETINOPATHY OR NOT? |
Bundy, David |
|
Feb 1, 2022 |
505 |
| FDA Approves Genentech's Vabysmo, the First Bispecific Antibody for the Eye, to Treat Two Leading Causes of Vision Loss. |
|
|
Jan 31, 2022 |
549 |
| Kriya Licenses Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases. |
|
|
Jan 27, 2022 |
312 |
| Gran bionic eye a UK 1st; Microchip under retina 'partially restores vision'. |
MARTIN BAGOT |
|
Jan 21, 2022 |
358 |
| Gran bionic eye a UK 1st; Microchip under retina 'partially restores vision'. |
MARTIN BAGOT Health Editor |
|
Jan 21, 2022 |
365 |
| Gran becomes first UK patient to be fitted with bionic eye in science breakthrough; The 88-year-old woman underwent an operation at Moorfield Eye Hospital in London, having a 2mm wide microchip under her retina. The chip offers the hope of partially restored vision. |
By, Martin Bagot |
|
Jan 21, 2022 |
353 |
| Ribomic Posts Preliminary Topline Data from Phase 2 Trials of RBM-007 for Wet Age-Related Macular Degeneration. |
|
Clinical report |
Jan 3, 2022 |
438 |
| LINEAGE & GENENTECH PARTNER ON RPE CELL THERAPY. |
|
|
Jan 1, 2022 |
533 |
| Fixation Stability and Preferred Retinal Locus in Advanced Age-Related Macular Degeneration. |
Altinbay, Deniz; Idil, Sefay Aysun |
Clinical report |
Jan 1, 2022 |
4949 |
| EFFECTS OF UNILATERAL INTRAVITREAL BEVACIZUMAB ON THE CONTRALATERAL EYE HAVING DIABETIC MACULAR EDEMA. |
Aziz Jan Bashir, Abdul Hannan, Salman Sohail Chaudhary, Sarah Zafar, Abdullah Naeem Syed and Syed Ha |
|
Dec 31, 2021 |
1802 |
| EVALUATION OF CHOROID THICKNESS CHANGES AFTER UNEVENTFUL PHACOEMULSIFICATION SURGERY USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AT A TERTIARY CARE EYE HOSPITAL. |
Aisha Rafique, Omar Zafar, Summaya Khan and Hassaan Javaid |
|
Dec 31, 2021 |
2672 |
| Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm. |
Ali Said, Yasmin; Dewilde, Evelien; Stalmans, Peter |
|
Dec 30, 2021 |
4300 |
| PQQ: Revitalizes Aging Energy Cells. |
McCulloch, Marsha |
|
Dec 22, 2021 |
2677 |
| Fourth Case Of Retinal Tissue Restoration With OpRegen. |
|
Clinical report |
Dec 20, 2021 |
729 |
| Lineage Establishes Exclusive Worldwide Collaboration with Genentech for the Development and Commercialization of OpRegen RPE Cell Therapy for the Treatment of Ocular Disorders. |
|
|
Dec 20, 2021 |
565 |
| Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications. |
Fragiotta, Serena; Abdolrahimzadeh, Solmaz; Dolz-Marco, Rosa; Sakurada, Yoichi; Gal-Or, Orly; Scuder |
|
Dec 17, 2021 |
9168 |
| Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. |
Huber, Anna Lena; Angermann, Reinhard; Nowosielski, Yvonne; Seifarth, Christof; Kralinger, Martina T |
|
Dec 15, 2021 |
4132 |
| The value of eye health in the digital era. |
|
|
Nov 22, 2021 |
490 |
| REGENXBIO Inc completes with AbbVie Collaboration and License Agreement. |
|
|
Nov 10, 2021 |
254 |
| REGENXBIO Inc completes with AbbVie Collaboration and License Agreement. |
|
|
Nov 10, 2021 |
255 |
| Adverum Biotechnologies reports Q3 EPS (39c), consensus (37c). |
|
Financial report |
Nov 4, 2021 |
179 |
| Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration. |
Kawakami, Setsuko; Wakabayashi, Yoshihiro; Umazume, Kazuhiko; Usui, Yoshihiko; Muramatsu, Daisuke; A |
|
Nov 2, 2021 |
6066 |
| MicroRNA-27a Promotes Oxidative-Induced RPE Cell Death through Targeting FOXO1. |
Ren, Chengda; Hu, Weinan; Wei, Qingquan; Cai, Wenting; Jin, Huizi; Yu, Donghui; Liu, Chang |
Report |
Nov 1, 2021 |
7974 |
| Curacle and ThA(c)a Ink Licensing and Collaboration Agreement for the Development and Commercialization of Orally Administered Treatment for Diabetic Macular Edema and Wet-AMD. |
|
|
Oct 27, 2021 |
414 |
| Experts warn of blindness due to diabetes. |
|
|
Oct 25, 2021 |
337 |
| Experts warn of blindness due to diabetes. |
|
|
Oct 25, 2021 |
337 |
| Diabetes eye disorders can lead to blindness: Experts. |
|
|
Oct 23, 2021 |
340 |
| FDA approves Genentech's Susvimo. |
|
|
Oct 22, 2021 |
166 |
| FDA Approves Genentech's Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration. |
|
|
Oct 22, 2021 |
1244 |
| Opthea announces patient enrollment for OPT-302 Phase 3 clinical program. |
|
|
Oct 19, 2021 |
179 |
| EyePoint presents positive safety data from Phase 1 trial of EYP-1901. |
|
|
Oct 12, 2021 |
187 |
| Ocuphire Pharma announces publications featuring Ref-1 protein. |
|
|
Oct 7, 2021 |
377 |
| 4D Molecular announces FDA clearance of IND application for 4D-150. |
|
|
Oct 6, 2021 |
301 |
| Unity Biotechnology announces 12-week data from Phase 1 trial of UBX1325. |
|
|
Oct 5, 2021 |
402 |
| Opthea opens patient recruitment in Europe for Phase 3 ShORe, COAST trials. |
|
|
Oct 4, 2021 |
218 |
| Coherus Biosciences announces results from COLUMBUS-AMD trial. |
|
|
Oct 4, 2021 |
187 |
| Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. |
Bereimipour, Ahmad; Satarian, Leila; Taleahmad, Sara |
Report |
Oct 4, 2021 |
6741 |
| Regenxbio announces Suprachoroidal delivery of RGX-314 well tolerated. |
|
|
Oct 1, 2021 |
439 |
| Graybug Vision reports analysis of data from ALTISSIMO Phase 2b trial. |
|
|
Sep 28, 2021 |
270 |
| Outlook Therapeutics reports 12-month safety data from Phase 3 NORSE TWO trial. |
|
|
Sep 28, 2021 |
491 |
| Clearside Biomedical completes dosing in Cohort 2 of Phase 1/2a of CLS-AX. |
|
|
Sep 21, 2021 |
189 |
| Eye condition can increase dementia risk; in brief. |
|
|
Sep 14, 2021 |
341 |
| AbbVie, Regenxbio announce partnership to develop and commercialize RGX-314. |
|
|
Sep 13, 2021 |
260 |
| Apellis plans NDA for pegcetacoplan for GA to FDA after studies met endpoint. |
|
|
Sep 9, 2021 |
418 |
| Alleye mobile app helps users detect visual distortion. |
Daily News Egypt |
|
Sep 1, 2021 |
346 |
| PLANT PIGMENTS PROTECT AGAINST VISION LOSS. |
Downey, Michael |
Cover story |
Sep 1, 2021 |
2661 |
| Hero Harry offers sight-loss support. |
|
|
Aug 25, 2021 |
442 |
| Regeneron's ongoing phase 2 trial of 8mg dose of aflibercept met safety endpoint. |
|
|
Aug 24, 2021 |
264 |
| Community service is keeping an eye on serious conditions. |
MARK SMITH Health correspondent mark.smith@walesonline.co.uk |
|
Aug 23, 2021 |
775 |
| How to save your sight. |
|
|
Aug 10, 2021 |
707 |
| Opthea expands global Phase 3 ShORe, COAST Wet AMD trials of OPT-302 to Canada. |
|
|
Aug 9, 2021 |
283 |
| Polpharma Biologics Group JV Bioeq Has Submitted a Biologics License Application for Biosimilar Ranibizumab to the US Food and Drug Administration. |
|
|
Aug 9, 2021 |
442 |
| Outlook Therapeutics reports 'positive' data from Phase 3 NORSE TWO trial. |
|
|
Aug 3, 2021 |
182 |
| First Patient Dosed in US-based Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet Age-Related Macular Degeneration. |
|
|
Aug 2, 2021 |
550 |
| Improvements In Patients With Dry AMD With Geographic Atrophy. |
|
Clinical report |
Aug 2, 2021 |
239 |
| Don't Let Age-Related Macular Degeneration Steal Your Sight: Eye exams are essential; the earlier AMD is diagnosed and treated, the less likely it is to cause blindness. |
|
|
Aug 1, 2021 |
777 |
| Roche's faricimab application accepted by US FDA. |
|
|
Jul 30, 2021 |
200 |
| Roche's faricimab application accepted by US FDA. |
|
|
Jul 30, 2021 |
201 |
| Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option. |
Qin, Shuqi; Dong, Ning; Yang, Ming; Wang, Jialin; Feng, Xue; Wang, Yanling |
|
Jul 30, 2021 |
13772 |
| Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura Ahead of Schedule. |
|
|
Jul 27, 2021 |
555 |
| Iveric bio completes patient enrollment in clinical trial of Zimura. |
|
|
Jul 26, 2021 |
369 |
| Unity Biotechnology to host investor call on Phase 1 trial of UBX1325. |
|
|
Jul 23, 2021 |
162 |
| Adverum Biotechnologies no longer plans future development for DME in INFINITY. |
|
|
Jul 22, 2021 |
293 |
| Iveric bio appoints Christopher Simms as Chief Commercial Officer. |
|
|
Jul 19, 2021 |
183 |
| Polpharma Biologics JV Company, Bioeq, Has Entered Into a Commercialization Agreement for Biosimilar Ranibizumab. |
|
|
Jul 8, 2021 |
569 |
| Iveric Bio Receives FDA Agreement Under Special Protocol Assessment for GATHER2 Phase 3 Clinical Trial of Zimura in Geographic Atrophy Secondary to Age-Related Macular Degeneration. |
|
|
Jul 7, 2021 |
783 |
| Iveric bio receives FDA agreement under SPA for GATHER2 Phase 3 trial. |
|
|
Jul 6, 2021 |
424 |
| Opthea's OPT-302 granted Fast Track designation for wet AMD. |
|
|
Jul 6, 2021 |
157 |
| EyePoint reports 30-day safety results for all cohorts from DAVIO trial. |
|
Financial report |
Jul 6, 2021 |
223 |
| Vision Improves In Some Advanced Dry AMD patients After Stem Cell Implant. |
|
|
Jul 5, 2021 |
682 |
| I Can See Clearly Now: How to protect your vision. |
Chew, Emily |
Interview |
Jul 1, 2021 |
2572 |
| MANAGEMENT OF LOW VISION IN PEOPLE WITH MYOPIC MACULAR DEGENERATION. |
Mufarriq Shah and Muhammad Tariq Khan |
|
Jun 30, 2021 |
3206 |
| Ocular Therapeutix, Mosaic Biosciences team on macular degeneration. |
|
|
Jun 29, 2021 |
212 |
| Samsung Bioepis, Biogen receive positive CHMP opinion for BYOOVIZ. |
|
|
Jun 25, 2021 |
156 |
| Causes of blurry vision ... |
Etingin, Orli R. |
|
Jun 25, 2021 |
318 |
| Iveric bio to present GATHER2 enrollment data, GATHER1 analyses. |
|
|
Jun 18, 2021 |
236 |
| PanOptica Inks Licensing Agreement with Zhaoke Ophthalmology for PAN-90806 for the Treatment of Neovascular Eye Diseases in China, South Korea, and Southeast Asia. |
|
|
Jun 18, 2021 |
682 |
| Clearside report 'positive' safety results from OASIS Phase 1/2a trial of CLS-AX. |
|
|
Jun 15, 2021 |
255 |
| On the Horizon: New Treatments for Acute Macular Degeneration: Therapies may become more convenient for people with the condition. |
|
|
Jun 9, 2021 |
1081 |
| Data affirms benefits of Bausch + Lomb formula. |
|
|
Jun 7, 2021 |
275 |
| Companies Partner To Develop iPS Cell Therapies For Eye Diseases. |
|
|
Jun 7, 2021 |
370 |
| Lineage Cell Therapeutics annonces new patients with retinal tissue restoration. |
|
|
Jun 1, 2021 |
251 |
| OCTOPUS VISION TEST COULD HELP PINPOINT PATIENTS AT RISK OF AMD. |
|
|
Jun 1, 2021 |
222 |
| Macula, magnifiers and more: This article describes the impact of visual impairment on patients with age-related macular degeneration and how this can be managed. |
Tooth, Cirta |
|
Jun 1, 2021 |
2436 |
| Outlook Therapeutics provides recap of virtual Clinical Day. |
|
|
May 27, 2021 |
195 |
| Bausch + Lomb announces positive new National Eye Institute Data regarding AREDS2 Nutrient Formula for advanced age-related macular degeneration. |
|
|
May 12, 2021 |
230 |
| Bausch + Lomb announces positive new National Eye Institute Data regarding AREDS2 Nutrient Formula for advanced age-related macular degeneration. |
|
|
May 12, 2021 |
231 |
| Ocugen presents new preclinical data on OCU200 at ARVO annual meeting. |
|
|
May 6, 2021 |
212 |
| Adverum Biotechnologies presents long-term data from OPTIC trial of ADVM-022. |
|
|
May 2, 2021 |
221 |
| Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration. |
Kiyat, Pelin; Mentes, Jale; Nalcaci, Serhad; Afrashi, Filiz; Baris, Mine |
Clinical report |
May 1, 2021 |
5170 |
| The Use of Fundus Autofluorescence in Dry Age-Related Macular Degeneration. |
Kegkek, Nedime Sahinoglu; Cermet, Figen |
|
May 1, 2021 |
5617 |
| Outlook Therapeutics is bringing a treatment for retinal disease to the market at the right time. |
|
|
Apr 30, 2021 |
1280 |
| Incidence of endophthalmitis following intravitreal anti VEGF injections at a tertiary care hospital in Pakistan. |
Shaheen, Fiza; Awan, Muhammad Amer; Hafeez, Aiman; Haq, Aqdus; Zainab, Ramsha |
Report |
Apr 30, 2021 |
2552 |
| IL-9 and IL-10 Single-Nucleotide Variants and Serum Levels in Age-Related Macular Degeneration in the Caucasian Population. |
Vilkeviciute, Alvita; Cebatoriene, Dzastina; Kriauciuniene, Loresa; Zemaitiene, Reda; Liutkeviciene, |
|
Apr 13, 2021 |
10665 |
| Bausch + Lomb offers range of products for trying times. |
|
|
Apr 5, 2021 |
929 |
| Thousands will go blind as eye appointments missed. |
EXCLUSIVE BY MARTIN BAGOT Health Editor |
|
Apr 5, 2021 |
215 |
| Adverum Biotechnologies announces senior appointments for patient access. |
|
|
Mar 30, 2021 |
233 |
| Lineage Cell says vitelliform maculopathy patient treated with OpRegen. |
|
|
Mar 29, 2021 |
336 |
| Lineage Cell Therapeutics releases interim data on OpRegen for dry AMD. |
|
Clinical report |
Mar 23, 2021 |
462 |
| Unity Biotechnology reports Q4 EPS (37c), consensus (47c). |
|
Financial report |
Mar 23, 2021 |
157 |
| Assessment of Modified Patient Education Materials for People with Age-Related Macular Degeneration. |
Fortuna, Jennifer; Riddering, Anne; Shuster, Linda; Lopez-Jeng, Cassie |
|
Mar 22, 2021 |
7299 |
| PENSIONER SALUTES CHARITY; Catherine's sight loss assistance proves vital. |
KARLA SINCLAIR |
|
Mar 17, 2021 |
749 |
| HEALTH NEWS; Pollution linked to sight loss. |
DR MIRIAM STOPPARD |
|
Mar 16, 2021 |
152 |
| Pollution linked to sight loss; HEALTH NEWS. |
DR MIRIAM STOPPARD |
|
Mar 16, 2021 |
152 |
| Common HIV drugs may help prevent leading cause of vision loss. |
|
|
Mar 1, 2021 |
231 |
| Living Life Fully with Macular Degeneration. |
Polak, Doris Winn |
|
Mar 1, 2021 |
265 |
| Queue jumper attacks blind man. |
|
|
Feb 28, 2021 |
258 |
| 10 Ways to Improve Your Eyesight. |
|
|
Feb 25, 2021 |
808 |
| Gyroscope Therapeutics Touts Positive Interim Data from Phase I/II FOCUS Trial of Investigational Gene Therapy GT005. |
|
|
Feb 16, 2021 |
540 |
| Roche antibody shows promise for macular degeneration. |
|
|
Feb 15, 2021 |
551 |
| Roche Reports Positive Faricimab New Phase 3 Study Results. |
|
|
Feb 12, 2021 |
199 |
| Gemini Therapeutics Completes Enrollment in Phase 2a Trial of GEM103 in Dry Age-Related Macular Degeneration (AMD) in Patients with High-Risk Genetic Variants. |
|
|
Feb 11, 2021 |
634 |
| Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs). |
Yu, Jeffrey J.; Azzam, Daniel B.; Chwa, Marilyn; Schneider, Kevin; Cho, Jang-Hyeon; Hsiang, Chinhui; |
|
Feb 9, 2021 |
9435 |
| New treatment on NHS can slow down eye disease. |
SONIA SHARMA Reporter sonia.sharma@reachplc.com |
|
Feb 8, 2021 |
657 |
| Sight for sore eyes; new treatment could benefit sufferers of degenerative eye disease. |
SONIA SHARMA Reporter sonia.sharma@reachplc.com |
|
Feb 8, 2021 |
648 |
| Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography. |
Wu, Jing; Zhang, Chaoyang; Yang, Qian; Xie, Hai; Zhang, Jingting; Qiu, Qinghua; Liu, Kun; Luo, Dawei |
Report |
Feb 4, 2021 |
4805 |
| SCIENCE AND VISION. |
|
|
Feb 1, 2021 |
196 |
| How do you talk to your patients about AMD? |
Edwards, Richard; Oakley, Sarah |
|
Feb 1, 2021 |
3573 |
| Genentech's Faricimab Meets Primary Endpoint in Two Global Phase III Studies. |
|
|
Jan 26, 2021 |
638 |
| Study: Air pollution linked to irreversible sight loss. |
|
|
Jan 26, 2021 |
449 |
| Roche's Faricimab Meets Primary Endpoint; Renews Contract With Sysmex. |
|
|
Jan 25, 2021 |
252 |
| The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration. |
Ahmed, Daniel; Stattin, Martin; Haas, Anna-Maria; Kickinger, Stefan; Gabriel, Maximilian; Graf, Alex |
|
Jan 1, 2021 |
4842 |
| Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-ß /Smad Signaling Pathway. |
Gao, Chuang; Cao, Xin; Huang, Lili; Bao, Yueqi; Li, Tao; Di, Yue; Wu, Liucheng |
|
Jan 1, 2021 |
4838 |
| Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis. |
Randazzo, Alessandro; Raimondi, Raffaele; Fossati, Giovanni; Romano, Mary; Sorrentino, Tania; Castel |
|
Jan 1, 2021 |
2750 |
| Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. |
Bereimipour, Ahmad; Satarian, Leila; Taleahmad, Sara |
Report |
Jan 1, 2021 |
6742 |
| Short-Term Outcomes following “Switching” to Monthly Ranibizumab in Neovascular Age-Related Macular Degeneration Showing Insufficient Response to Bimonthly Aflibercept. |
Lee, Jong Suk; Kang, Hyun Goo; Lee, Christopher Seungkyu; Woo, Se Joon |
|
Jan 1, 2021 |
4365 |
| Causes and Five-Year Proportion of New Irreversible Visual Impairment in Jinshan District, Shanghai, from 2009-2018. |
Li, Tao; Zhou, Xiaodong |
|
Jan 1, 2021 |
4030 |
| OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review. |
Metrangolo, Cristian; Donati, Simone; Mazzola, Marco; Fontanel, Liviana; Messina, Walter; D'alterio, |
|
Jan 1, 2021 |
11383 |
| Mechanism of Nucleic Acid Sensing in Retinal Pigment Epithelium (RPE): RIG-I Mediates Type I Interferon Response in Human RPE. |
Schustak, Joshua; Twarog, Michael; Wu, Xiaoqiu; Wu, Henry Y.; Huang, Qian; Bao, Yi |
|
Jan 1, 2021 |
10036 |
| Visual Function and Patient Satisfaction with Multifocal Intraocular Lenses in Patients with Glaucoma and Dry Age-Related Macular Degeneration. |
Sánchez-Sánchez, Carmen; Rementería-Capelo, Laureano A.; Puerto, Beatriz; López-Caballero, Cristina; |
|
Jan 1, 2021 |
4278 |
| Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography. |
Azar, Georges; Vasseur, Vivien; Lahoud, Corinne; Favard, Catherine; De Bats, Flore; Cochereau, Isabe |
Report |
Jan 1, 2021 |
4234 |
| Clinical Features, Prognosis, and Long-Term Response to Ranibizumab of Macular CNVs in Pattern Dystrophies Spectrum: A Pilot Study. |
Casillo, Lorenzo; Tricarico, Stefano; Contento, Laura; Vingolo, Enzo M. |
|
Jan 1, 2021 |
4818 |
| Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion. |
Kim, Jae Hui; Kim, Jong Woo; Kim, Chul Gu |
|
Jan 1, 2021 |
6064 |
| Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen. |
Kamao, Hiroyuki; Goto, Katsutoshi; Matsuno, Kento; Mizukawa, Kenichi; Miki, Atsushi; Kiryu, Junichi |
|
Jan 1, 2021 |
5651 |
| Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection. |
Kaya, Mahmut; Oner, Ferit Hakan; Yagci, Betul Akbulut; Atas, Ferdane; Ozturk, Taylan |
|
Jan 1, 2021 |
3793 |
| Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration. |
Avci, Remzi; Yildiz, Aysegul Mavi; Cinar, Esat; Yilmaz, Sami; Kucukerdonmez, Cem; Akalp, Fatma Duriy |
|
Jan 1, 2021 |
4452 |
| MicroRNA-27a Promotes Oxidative-Induced RPE Cell Death through Targeting FOXO1. |
Ren, Chengda; Hu, Weinan; Wei, Qingquan; Cai, Wenting; Jin, Huizi; Yu, Donghui; Liu, Chang |
Report |
Jan 1, 2021 |
7974 |
| Janssen Acquires Rights to Eye Disorder Gene Therapy from Hemera Biosciences. |
|
|
Dec 3, 2020 |
166 |
| Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration. |
You, Jong In; Kim, Kiyoung |
|
Dec 3, 2020 |
4081 |
| How technology can help to future-proof a wet AMD service. |
Powell, Selina |
|
Dec 1, 2020 |
247 |
| Light for sight. |
Elks, David |
|
Dec 1, 2020 |
3040 |
| Fixed Regimen Treatment in Unselected Naïve Patients Cohort with Neovascular Age-Related Macular Degeneration. |
Casaroli-Marano, Ricardo P.; Bernal-Morales, Carolina; Chamorro-López, Lillian; Dotti-Boada, Marina; |
|
Nov 21, 2020 |
5189 |
| Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane. |
|
|
Nov 12, 2020 |
163 |
| Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane. |
|
|
Nov 12, 2020 |
158 |
| Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane. |
|
|
Nov 12, 2020 |
162 |
| Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen Cell Therapy for the Treatment of Dry Age-related Macular Degeneration. |
|
Clinical report |
Nov 11, 2020 |
595 |
| Bausch + Lomb's core offerings meet array of vision needs. |
|
|
Nov 9, 2020 |
808 |
| The Prevalence of Undiagnosed Age-Related Sight-Threatening Diseases in Self-Proclaimed Healthy Individuals. |
Lemmens, Sophie; Barbosa Breda, João; Van Keer, Karel; Jacobs, Tine; Van Landeghem, Ruben; De Boever |
Clinical report |
Nov 7, 2020 |
6857 |
| Ways to Improve Your Eyesight. |
|
|
Oct 29, 2020 |
1027 |
| First Patient Received Investigational Gene Therapy GT005 Via Orbit Subretinal Delivery System in Ongoing Phase I/II FOCUS Trial. |
|
|
Oct 28, 2020 |
368 |
| Guardion Health Sciences announces investigator-initiated trial of Lumega-Z. |
|
|
Oct 26, 2020 |
311 |
| Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease. |
Herranz-Heras, Juan-Carlos; de-Pablo-Cabrera, Almudena; Alonso-Martín, Beatriz; de-Lucas-Viejo, Beat |
|
Oct 21, 2020 |
4654 |
| Luteolin Attenuates IL-1ß -Induced THP-1 Adhesion to ARPE-19 Cells via Suppression of NF-? B and MAPK Pathways. |
Huang, Wen-Chung; Liou, Chian-Jiun; Shen, Szu-Chuan; Hu, Sindy; Hsiao, Chien-Yu; Wu, Shu-Ju |
|
Oct 16, 2020 |
6779 |
| Alzheimer's Disease as a Result of Stimulus Reduction in a GABA-A-Deficient Brain: A Neurocomputational Model. |
Aguiar-Furucho, Mariana Antonia; Peláez, Francisco Javier Ropero |
|
Oct 14, 2020 |
17608 |
| Optician backs no smoking and alcohol challenges. |
|
|
Oct 14, 2020 |
374 |
| Outlook Therapeutics initiates supplemental open-label safety study of ONS-5010. |
|
|
Oct 13, 2020 |
404 |
| Age-Related Macular Degeneration and Cardiovascular Diseases and Risk Factors Associated with It--A Cross Sectional Study in Kerala. |
Deepa, M.G.; Sija, S.; Jacob, K.K.; Rajeevan, P. |
|
Oct 12, 2020 |
3582 |
| Phillyrin Mitigates Apoptosis and Oxidative Stress in Hydrogen Peroxide-Treated RPE Cells through Activation of the Nrf2 Signaling Pathway. |
Du, Yuanyuan; You, Longtai; Ni, Boran; Sai, Na; Wang, Wenping; Sun, Mingyi; Xu, Rui |
|
Oct 12, 2020 |
8473 |
| Help your eyes with 'Stoptober' annual challenge. |
|
|
Oct 7, 2020 |
248 |
| Hinsdale-Based Visible Genomics Announces Four New Appointments to Board of Clinical Advisors. |
Creative Marketing Associates |
|
Oct 6, 2020 |
420 |
| Ocugen engages Kemwell Biopharma for cGMP manufacture of OCU200. |
|
|
Oct 6, 2020 |
216 |
| Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial. |
Ziemssen, Focke; Hammer, Thomas; Grueb, Matthias; Mueller, Bettina; Berk, Hüsnü; Gamulescu, Maria-An |
Clinical report |
Oct 6, 2020 |
9574 |
| Fortified S-Allyl L-Cysteine: Animal Safety, Effect on Retinal Ischemia, and Role of Wnt in the Underlying Therapeutic Mechanism. |
Chao, Windsor Wen-Jin; Chen, Yu-Kuang; Chao, Howard Wen-Haur; Pan, Wynn Hwai-Tzong; Chao, Hsiao-Ming |
|
Oct 5, 2020 |
7761 |
| Eye up challenge for your health. |
|
|
Oct 5, 2020 |
199 |
| Novartis Notes Phase III Trial Showing Improved Beovu Treatment. |
|
|
Oct 5, 2020 |
221 |
| Kodiak Sciences: First patients treated in Phase 3 Studies of KSI-301. |
|
|
Oct 5, 2020 |
156 |
| Eyevensys Receives FDA Orphan Drug Designation for EYS611 for Treatment of Retinitis Pigmentosa. |
|
|
Oct 5, 2020 |
620 |
| Apellis announces results of post hoc analysis of Phase 2 FILLY study. |
|
|
Oct 4, 2020 |
238 |
| Visible Genomics Announces Four New Appointments to Board of Clinical Advisors. |
Creative Marketing Associates |
|
Oct 2, 2020 |
952 |
| Lineage Cell Therapeutics busy working on treatments relating to Dry AMD and spinal cord injury. |
|
|
Oct 2, 2020 |
158 |
| Periodontal Disease and Age-Related Macular Degeneration: A Meta-Analysis of 112,240 Participants. |
Lv, Xuewen; Li, Weiqi; Fang, Zhiyu; Xue, Xiaofei; Pan, Chunling |
Report |
Sep 29, 2020 |
5995 |
| Does Cataract Surgery Improve the Progression of Age-Related Macular Degeneration? A Meta-Analysis. |
Liu, Yuanyuan; Cai, Qinhua |
|
Sep 27, 2020 |
6893 |
| Astellas Pharma collaborates with University of Pittsburgh. |
|
|
Sep 25, 2020 |
257 |
| Astellas Pharma collaborates with University of Pittsburgh. |
|
|
Sep 25, 2020 |
253 |
| Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration. |
|
|
Sep 22, 2020 |
300 |
| Exploring Associations Between Health Literacy and Visual Impairment in Older Adults with Age-Related Macular Degeneration (AMD). |
Fortuna, Jennifer |
|
Sep 22, 2020 |
4322 |
| Bausch Health to Acquire Option to Purchase All Ophthalmology Assets of Allegro Ophthalmics. |
|
|
Sep 21, 2020 |
404 |
| Visible Genomics launches DNA age-related macular degeneration testing. |
Submitted by Creative Marketing Associates |
|
Sep 17, 2020 |
541 |
| Visible Genomics Launches DNA Age-Related Macular Degeneration Testing. |
Creative Marketing Associates |
|
Sep 16, 2020 |
547 |
| Readers continue to worry about COVID-19 Doctors: Soft drusen can lead to macular degeneration. |
|
|
Sep 14, 2020 |
1009 |
| Drusen severity depends on the type. |
Dr. Eve Glazier and Dr. Elizabeth Ko |
|
Sep 14, 2020 |
554 |
| Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration. |
Baris, Mine Esen; Mentes, Jale; Afrashi, Filiz; Nalcaci, Serhad; Akkin, Cezmi |
Clinical report |
Sep 1, 2020 |
5283 |
| Identification of Key Genes and Pathways Associated with Age-Related Macular Degeneration. |
Zhang, Junyu; Zhou, Yu |
|
Aug 31, 2020 |
5578 |
| Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up. |
Javidi, Simon; Dirani, Ali; Antaki, Fares; Saab, Marc; Rahali, Sofiane; Cordahi, Ghassan |
Clinical report |
Aug 31, 2020 |
9050 |
| The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review. |
Wang, Yimin; Shen, Mengxi; Cheng, Jinwei; Sun, Xiaodong; Kaiser, Peter K. |
Report |
Aug 31, 2020 |
7296 |
| Effect of the Duration of Intraretinal or Subretinal Fluid on the Response to Treatment in Undertreated Age-Related Macular Degeneration. |
Yoshida, Izumi; Sakamoto, Masashi; Sakai, Asao; Maeno, Takatoshi |
|
Aug 31, 2020 |
5395 |
| Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study. |
Ruiz-Moreno, Jose M.; Ruiz-Medrano, Jorge; Lugo, Francisco; Sirvent, Belen; Flores-Moreno, Ignacio |
|
Aug 31, 2020 |
3899 |
| Detrimental Effects of UVB on Retinal Pigment Epithelial Cells and Its Role in Age-Related Macular Degeneration. |
Mahendra, Camille Keisha; Tan, Loh Teng Hern; Pusparajah, Priyia; Htar, Thet Thet; Chuah, Lay-Hong; |
|
Aug 31, 2020 |
20176 |
| Protective Effect of Metformin against Hydrogen Peroxide-Induced Oxidative Damage in Human Retinal Pigment Epithelial (RPE) Cells by Enhancing Autophagy through Activation of AMPK Pathway. |
Zhao, Xia; Liu, Linlin; Jiang, Yizhou; Silva, Marta; Zhen, Xuechu; Zheng, Wenhua |
|
Aug 31, 2020 |
8277 |
| Autophagy in Age-Related Macular Degeneration: A Regulatory Mechanism of Oxidative Stress. |
Zhang, Zi-Yuan; Bao, Xiao-Li; Cong, Yun-Yi; Fan, Bin; Li, Guang-Yu |
|
Aug 31, 2020 |
10274 |
| Autophagy Upregulation by the TFEB Inducer Trehalose Protects against Oxidative Damage and Cell Death Associated with NRF2 Inhibition in Human RPE Cells. |
Abokyi, Samuel; Shan, Sze wan; To, Chi-ho; Chan, Henry Ho-lung; Tse, Dennis Yan-yin |
|
Aug 31, 2020 |
10365 |
| Tribulus terrestris Ameliorates Oxidative Stress-Induced ARPE-19 Cell Injury through the PI3K/Akt-Nrf2 Signaling Pathway. |
Yuan, Zhenli; Du, Weiwei; He, Xiangdong; Zhang, Donglei; He, Wei |
|
Aug 31, 2020 |
9331 |
| New Understanding of Genetic Changes in the Eye. |
|
|
Aug 26, 2020 |
209 |
| Outlook Therapeutics reports topline results from NORSE 1 study. |
|
|
Aug 26, 2020 |
432 |
| Gyroscope Therapeutics Initiates Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular Degeneration. |
|
|
Aug 13, 2020 |
671 |
| Kodiak Sciences reports Q2 EPS (58c), consensus (66c). |
|
Financial report |
Aug 10, 2020 |
395 |
| Regenxbio sees starting RGX-314 subretinal delivery pivotal program by end 2020. |
|
|
Aug 4, 2020 |
256 |
| OCT findings in age-related macular degeneration. |
Epshtein, Daniel |
|
Aug 1, 2020 |
599 |
| Metformin Protects ARPE-19 Cells from Glyoxal-Induced Oxidative Stress. |
Qu, Sichang; Zhang, Chaoyang; Liu, Dandan; Wu, Jing; Tian, Haibin; Lu, Lixia; Xu, Guo-Tong; Liu, Fan |
|
Jul 31, 2020 |
7174 |
| Corrigendum to "Cathepsin B pH-Dependent Activity Is Involved in Lysosomal Dysregulation in Atrophic Age-Related Macular Degeneration". |
Voisin, Audrey; Monville, Christelle; Plancheron, Alexandra; Bere, Emile; Gaillard, Afsaneh; Levezie |
Correction notice |
Jul 31, 2020 |
241 |
| Renin-Angiotensin System Inhibitor Usage and Age-Related Macular Degeneration among Hypertensive Patients: Results from the National Health and Nutrition Examination Survey, 2005-2008. |
Ren, Chi; Liu, Weiming; Yin, Xue; Zhang, Bingyu; Lu, Peirong |
|
Jul 31, 2020 |
6579 |
| Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany. |
Wachtlin, Joachim; Spital, Georg; Schmitz-Valckenberg, Steffen; Liakopoulos, Sandra; Vogeler, Jessic |
Clinical report |
Jul 31, 2020 |
6660 |
| Novartis Sees Positive Beovu Analysis Results; Sandoz Plans Investment. |
|
|
Jul 27, 2020 |
386 |
| Clearside Biomedical announces multiple presentations at ASRS Annual Meeting. |
|
|
Jul 27, 2020 |
636 |
| NGM Biopharmaceuticals initiates Phase 2 CATALINA study of NGM621. |
|
|
Jul 27, 2020 |
210 |
| Genentech says Archway study data supports 'favorable' benefit-risk profile. |
|
|
Jul 22, 2020 |
468 |
| Keep an eye on the light and your sight; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. |
Francesca Marchetti |
|
Jul 21, 2020 |
778 |
| Look out for your eyesight this summer; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. |
|
|
Jul 21, 2020 |
1050 |
| Look out for your eyesight this summer; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. |
Francesca Marchetti |
|
Jul 21, 2020 |
1054 |
| Blind ex-Navy man urges runners to join in challenge. |
LISA O'BRIEN lisa.obrien@mnamedia.co.uk |
|
Jul 11, 2020 |
370 |
| Kodiak Sciences reports 'promising' safety data from KSI-301 Phase 1b study. |
|
|
Jul 10, 2020 |
283 |
| First Patient Dosed in Second Zimura Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration. |
|
|
Jul 2, 2020 |
513 |
| Stargardt Disease and Approaches to Learning for Individuals with This Condition. |
Davis, Alexis Poe; Bullard-Maxwell, Amanda; Stone-Hernandez, Regina; Chiarolanzio, Emily; Griffin, H |
Report |
Jul 1, 2020 |
3463 |
| Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration. |
Urban, Beata; Szwabowicz, Magdalena; Bakunowicz-Lazarczyk, Alina |
|
Jun 30, 2020 |
5135 |
| Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization. |
Zhang, Xiaoli; Zhu, Manhui; Xie, Laiqing; Sun, Xiaodong; Xu, Jiaowen; Guo, Yang; Liu, Dong; Shi, Yun |
|
Jun 30, 2020 |
7087 |
| Bioinformatical Analysis of miRNA-mRNA Interaction Network Underlying Macrophage Aging and Cholesterol-Responsive Difference between Young and Aged Macrophages. |
Li, Jianqing; Yin, Xue; Zhang, Bingyu; Li, Chen; Lu, Peirong |
|
Jun 30, 2020 |
4909 |
| Lineage Re-Starts Enrollment In Clinical Study Of Treatment For Dry AMD. |
|
|
Jun 29, 2020 |
845 |
| Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD. |
|
|
Jun 26, 2020 |
188 |
| Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD. |
|
|
Jun 26, 2020 |
184 |
| Lineage Cell Therapeutics reinitiates patient enrollment in OpRegen study. |
|
Clinical report |
Jun 18, 2020 |
176 |
| Clearside Biomedical announce presentations at ARVO 2020 meeting. |
|
|
Jun 17, 2020 |
529 |
| Outlook Therapeutics expects topline results from NORSE 1 study in August. |
|
|
Jun 17, 2020 |
510 |
| Iveric bio announces 18-month Zimura trial data. |
|
|
Jun 15, 2020 |
451 |
| Regeneration Of Retinal Tissue In Dry AMD Patient. |
|
|
Jun 15, 2020 |
709 |
| Novartis Adds Warning To Beovu Label In US After Safety Reports. |
|
|
Jun 11, 2020 |
403 |
| Lineage Cell Therapeutics reports findings from OpRegen study. |
|
|
Jun 1, 2020 |
330 |
